ResearcherUniversidad Fernando Pessoa CanariasActive in the last 2 years
Pedro C. Lara
Matched on ORCID iD 0000-0003-1709-6232; OpenAlex author ID A5002657236.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: none · 2027: 1 trial
Papers 4
- Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study. Last author DOI 10.3390/cancers17020191↗
- Inflammatory Biomarkers Predict Local Control and Survival After Escalated High-Dose SBRT in Borderline and Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/jcm14186573↗
- Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study. Last author DOI 10.1016/j.ctro.2024.100753↗
- Intraoperative radiotherapy with the Intrabeam® device for the treatment of resectable pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ciresp.2018.04.014↗
Trials 1
Closest collaborators
The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Laura Ferrera-Alayón · 3 shared papers, 2024–2025
- Paper Inflammatory Biomarkers Predict Local Control and Survival After Escalated High-Dose SBRT in Borderline and Locally Adv… DOI 10.3390/jcm14186573↗
- Paper Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results … DOI 10.3390/cancers17020191↗
- Paper Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical… DOI 10.1016/j.ctro.2024.100753↗
- Marta Lloret Sáez-Bravo · 3 shared papers, 2024–2025
- Paper Inflammatory Biomarkers Predict Local Control and Survival After Escalated High-Dose SBRT in Borderline and Locally Adv… DOI 10.3390/jcm14186573↗
- Paper Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results … DOI 10.3390/cancers17020191↗
- Paper Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical… DOI 10.1016/j.ctro.2024.100753↗
- Bárbara Salas-Salas · 3 shared papers, 2024–2025
- Paper Inflammatory Biomarkers Predict Local Control and Survival After Escalated High-Dose SBRT in Borderline and Locally Adv… DOI 10.3390/jcm14186573↗
- Paper Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results … DOI 10.3390/cancers17020191↗
- Paper Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical… DOI 10.1016/j.ctro.2024.100753↗
- Aida Cristina Rahy-Martín · 1 shared paper, 2018
- Joaquín Marchena-Gómez · 1 shared paper, 2018
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.